Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001231420 | SCV001403940 | pathogenic | not provided | 2022-05-15 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 958281). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with USH2A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys4424*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Baylor Genetics | RCV003462787 | SCV004206316 | likely pathogenic | Retinitis pigmentosa 39 | 2023-02-24 | criteria provided, single submitter | clinical testing | |
Ophthalmo- |
RCV002307704 | SCV002600272 | pathogenic | Usher syndrome type 2 | 2022-11-14 | no assertion criteria provided | clinical testing | Novel pathogenic variant. PVS1, PM2, PP5. https://franklin.genoox.com/clinical-db/variant/snp/chr1-215847981-G-T |